research Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-κB inhibition
This study found that in mouse models, the novel NF-κB inhibitor DHMEQ improved symptoms of atopic dermatitis as effectively as tacrolimus or betamethasone.